AI Summary
Reliance Life Sciences Private Ltd, an Exporter focused on pharmaceutical products, recorded a November 2024 outbound shipment of 253 kg (≈1.5 TEU) from South Riding Point, India to Jacksonville, FL, USA, dispatched to buyer Jamp Pharma Corp. The limited but consistent monthly record suggests a nascent export cadence, with a single partner and clear port routing that simplifies customs handling. For prospective Buyers, the company demonstrates capability to supply niche pharma items, though the modest shipment size indicates limited scale; potential partners should assess capacity for larger orders. For Customs Brokers, the shipment’s straightforward port chain and complete documentation (despite absent HS‑code details) facilitate predictable clearance, though ensuring proper HS‑code classification will be essential to avoid delays. Overall, Reliance Life Sciences offers a reliable source for specialized pharma exports with clear logistics, while emphasizing the need for robust compliance documentation to maximize customs efficiency.